Role of chemoradiotherapy in advanced carcinoma cervix

Journal of the Indian Medical Association

Volumn 104, Issue 8, 2006, Pages 432-438

  Mitra, Debabrata ^a   Ghosh, Basabraj ^a   Kar, Arunansu ^a   Basu, Soumen ^a   Deb, Asit Ranjan ^a,b   Sur, Prabir Kumar ^a,c  

^a MEDICAL COLLEGE AND HOSPITAL   (India)

^b NRS MEDICAL COLLEGE   (India)

^c INSTITUTE OF POST GRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Carcinoma cervix; Concurrent chemotherapy; Radiotherapy

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN;

ADULT; AGED; ANEMIA; ARTICLE; BLADDER DISEASE; BRACHYTHERAPY; CANCER STAGING; CANCER SURVIVAL; CHEMOTHERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DISEASE SEVERITY; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; INCIDENCE; KIDNEY DISEASE; MAJOR CLINICAL STUDY; NEUTROPENIA; PATIENT COMPLIANCE; PROCTITIS; RADIATION; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL; RECTUM DISEASE; SKIN DISEASE; THROMBOCYTOPENIA; UTERINE CERVIX CANCER;

EID: 33751510922     PISSN: 00195847     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Nandakumar A - National Cancer Registry Programme. Bangalore: ICMR, 2001.
2. Grigsby PW, Graham MV, Perez CA, Galakatos AE, Camel HM, Kao MS - Prospective phase I/II studies of definitive irradiation and chemotherapy for advanced gynecologic malignancies. Am J Clin Oncol 1996; 19: 1-6.
3. Chang HC, Lai CH, Chen MS, Chao AS, Chen LH, Soong YK - Preliminary results of concurrent radiotherapy and chemotherapy with cis-platinum, vincristine, and bleomycin in bulky, advanced cervical carcinoma: a pilot study. Gynecol Oncol 1992; 44: 182-8.
4. Lin JC, Ho ES, Jan JS, Yang, CH, Liu FS - High complete response rate of concomitant chemoradiotherapy for locally advanced squamous cell carcinoma of the uterine cervix. Gynecol Oncol 1996; 61: 101-8.
5. Shepherds JH - Staging announcement - FIGO staging of gynecologic cancer: cervical and vulval. Genecol Cancer 1995; 5: 319-23.
6. World Health Organisation - WHO Handbook for Reporting Results of Cancer Treatment: WHO Offset Publication No 48. Geneva: WHO, 1979.
7. Overgaard J, Bartelink H - Late effects consensus conference: RTOG/EORTC. Radiother Oncol 1995; 35: 4-82.
8. Jampolis S, Andras EJ, Fletcher GH - Analysis of sites and causes of failures of irradiation in invasive squamous cell carcinoma of the intact uterine cervix. Radiology 1975; 115: 681-5.
9. Malfetano J, Keys H, Kredenster D, Cunningham M, Kotlove D, Weiss L - Weekly cisplatin and radical radiation therapy for advanced, recurrent, and poor prognosis cervical carcinoma. Cancer 1993; 71: 3703-6.
10. Wong LC, Choo YC, Choy D, Sham JS, Ma HK - Long-term follow-up of potentiation of radiotherapy by cisplatinum in advanced cervical cancer. Gynecol Oncol 1989; 35: 159-63.
11. Keys HM, Bundy BN, Stehman FB, Muderspach LI, Chafe WE, suggs CL, et al - Cisplatin, radiation, and adjuvant hysterectomy compared With radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med 1999; 340: 1154-61.
12. Thomas G, Dembo A, Fyles A, Gadalla T, Beale F, Bean H, et al - Concurrent chemoradiation in advanced cervical cancer. Gynecol Oncol 1990; 38: 446-51.
13. Rose PG, Bundy BN, Watkins EB, Thigpen JT, Deppe G, Maiman MA, et al - Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 1999; 340: 1144-53.
14. Morris M, Eifel PJ, Lu J, Grigsby PW, Levenback C, Stevens RE, et al - Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med 1999; 340: 1137-43.
15. Chen MD, Paley PJ, Polish RA, Twiggs LB - Phase I trial of taxol as a radiation sensitiser with cisplatin in advanced cervical cancer. Gynecol Oncol 1997; 67: 131-6.
16. Grigsby PW, Lu JD, Mutch DG, Kim RY, Eifel PJ - Twice daily fractionation of external irradiation with brachytherapy and chemotherapy in carcinoma of the cervix with positive para-aortic lymph node: phase II study of Radiation Therapy Oncology Group 92: 10. Int J Radiat Oncol Biol Phys 1998; 41: 817-22.